150 related articles for article (PubMed ID: 38687430)
1. Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer.
Schaffar R; Benhamou S; Chappuis PO; Rapiti E
Breast Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38687430
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
3. Effect of young age, positive margins, and triple negative status on disease recurrence after breast conserving therapy.
Lertsithichai P; Sakulchairungreung B; Chirappapha P; Suvikapakornkul R; Wasuthit Y; Sukarayothin T; Leesombatpaiboon M; Kongdan Y
Gland Surg; 2016 Feb; 5(1):15-23. PubMed ID: 26855904
[TBL] [Abstract][Full Text] [Related]
4. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.
Arvold ND; Taghian AG; Niemierko A; Abi Raad RF; Sreedhara M; Nguyen PL; Bellon JR; Wong JS; Smith BL; Harris JR
J Clin Oncol; 2011 Oct; 29(29):3885-91. PubMed ID: 21900114
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer under age 40: a different approach.
Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
[TBL] [Abstract][Full Text] [Related]
6. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
Figueiredo JC; Ennis M; Knight JA; McLaughlin JR; Hood N; O'Malley F; Andrulis IL; Goodwin PJ
Breast Cancer Res Treat; 2007 Sep; 105(1):69-80. PubMed ID: 17115108
[TBL] [Abstract][Full Text] [Related]
7. A population-based study of treatment patterns, 10-year recurrence and breast cancer-specific mortality in a cohort of elderly patients with breast cancer.
Samman S; Cornacchi SD; Foster G; Thabane L; Thomson S; Lovrics O; Martin S; Lovrics PJ
Am J Surg; 2021 Aug; 222(2):361-367. PubMed ID: 33358573
[TBL] [Abstract][Full Text] [Related]
8. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
9. Patterns of loco regional failure in women with breast cancer treated by Postmastectomy Conformal Electron Beam Radiation Therapy (PMERT): Large scale single center experience.
Loganadane G; Xi Z; Xu HP; Grellier Adedjouma N; Bazire L; Fourquet A; Kirova YM
Clin Transl Radiat Oncol; 2017 Jun; 4():46-50. PubMed ID: 29594207
[TBL] [Abstract][Full Text] [Related]
10. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors and Survival According to Tumor Subtype in Women With Breast Cancer Brain Metastases.
Lopes S; Vieira I; Abreu M; Pousa I; Ferreira A; Sousa S; Pereira D
Curr Probl Cancer; 2022 Dec; 46(6):100866. PubMed ID: 36179388
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.
van Laar C; van der Sangen MJ; Poortmans PM; Nieuwenhuijzen GA; Roukema JA; Roumen RM; Tjan-Heijnen VC; Voogd AC
Eur J Cancer; 2013 Oct; 49(15):3093-101. PubMed ID: 23800672
[TBL] [Abstract][Full Text] [Related]
13. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis.
Goldberg M; Sutradhar R; Paszat L; Whelan TJ; Gu S; Fong C; Rakovitch E
Breast Cancer Res Treat; 2019 Aug; 176(3):657-667. PubMed ID: 31076954
[TBL] [Abstract][Full Text] [Related]
14. Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.
Bychkovsky BL; Guo H; Sutton J; Spring L; Faig J; Dagogo-Jack I; Battelli C; Houlihan MJ; Yeh TC; Come SE; Lin NU
Oncologist; 2016 Dec; 21(12):1495-1501. PubMed ID: 27551013
[TBL] [Abstract][Full Text] [Related]
15. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
16. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden.
Zhang Y; Wang QL; Zeng E; He W; Czene K
JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
[TBL] [Abstract][Full Text] [Related]
19. Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United States.
Sussell JA; Press DJ; Hansen SA; Kim E; Du Toit Y; Fung A
Adv Ther; 2023 Sep; 40(9):3857-3874. PubMed ID: 37358705
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
